Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDFT1 | P37268 | 11/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5542015 | 0.98 | FDFT1 (0.51) | FDFT1FFAR1FFAR4 | |
| SCHEMBL5545164 | 0.95 | FDFT1 (0.51) | FDFT1FFAR1FFAR4 | |
| SCHEMBL5540055 | 0.87 | FFAR1 (0.50) | FDFT1FFAR1FFAR4 | |
| SCHEMBL5535812 | 0.84 | FFAR1 (0.53) | FDFT1FFAR1FFAR4 | |
| SCHEMBL10106193 | 0.83 | PPARA (0.60) | FDFT1 | |
| SCHEMBL8625359 | 0.83 | FDFT1 (0.56) | FDFT1FFAR1 | |
| SCHEMBL416922 | 0.83 | MAOA (0.60) | FDFT1 | |
| SCHEMBL5539299 | 0.82 | FFAR1 (0.51) | FDFT1FFAR1FFAR4 | |
| SCHEMBL3028864 | 0.82 | MGLL (0.50) | FFAR1 | |
| SCHEMBL8862906 | 0.82 | MGLL (0.50) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| CN-118255941-A | Photopolymerizable composition for 3D printer comprising polymerizable monomer having allophanate bond | 株式会社松风 | 2024-06-28 | — | — | CN | disclosed |
| US-11981763-B2 | Resin composition for stereolithographic modeling | KURARAY NORITAKE DENTAL INC. (JP) | 2024-05-14 | — | — | US | disclosed |
| CN-114072439-B | Curable composition and resin composition for photofabrication comprising same | 株式会社可乐丽 | 2024-05-14 | — | — | CN | disclosed |
| CN-113993497-B | Curable composition and resin composition for photofabrication comprising same | 株式会社可乐丽 | 2024-03-22 | — | — | CN | disclosed |
| EP-3900693-B1 | USE OF A RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | KURARAY CO., LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| WO-2023127934-A1 | ENERGY-RAY-CURABLE COMPOSITION FOR THREE-DIMENSIONAL SHAPING USE, DENTAL STRUCTURE, MOUTHPIECE, TEETH-STRAIGHTENING MOUTHPIECE, AND METHOD FOR PRODUCING DENTAL STRUCTURE | クラレノリタケデンタル株式会社 | 2023-07-06 | — | — | WO | disclosed |
| US-20230210728-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF | KURARAY NORITAKE DENTAL INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| WO-2023120611-A1 | CURABLE DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2023-06-29 | — | — | WO | disclosed |
| WO-2021132699-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL MOLDING, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL MOLDING CONTAINING SAID SAME, THREE-DIMENSIONAL MOLDED PRODUCT OBTAINED USING SAME, AND METHOD FOR PRODUCING SAME | クラレノリタケデンタル株式会社 | 2021-07-01 | — | — | WO | disclosed |
| CN-112752776-A | Resin composition for stereolithography | 可乐丽则武齿科株式会社 | 2021-05-04 | — | — | CN | disclosed |
| WO-2021066073-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | クラレノリタケデンタル株式会社 | 2021-04-08 | — | — | WO | disclosed |
| WO-2020235628-A1 | RESIN COMPOSITION FOR OPTICAL THREE-DIMENSIONAL MODELING | クラレノリタケデンタル株式会社 (JP) | 2020-11-26 | — | — | WO | disclosed |
| CN-111971318-A | Photocurable resin composition | 可乐丽则武齿科株式会社 | 2020-11-20 | — | — | CN | disclosed |
| WO-2020218446-A1 | CURABLE COMPOSITION FOR DENTAL RESTORATION | クラレノリタケデンタル株式会社 | 2020-10-29 | — | — | WO | disclosed |
| WO-2020071552-A1 | RESIN COMPOSITION FOR OPTICAL SHAPING | クラレノリタケデンタル株式会社 | 2020-04-09 | — | — | WO | disclosed |
| WO-2019189566-A1 | PHOTOCURABLE RESIN COMPOSITION | クラレノリタケデンタル株式会社 | 2019-10-03 | — | — | WO | disclosed |
| US-6492364-B1 | Triazolo and derivatives as chemokine inhibitors | TORAY INDUSTRIES, INC. (JP) | 2002-12-10 | — | — | US | disclosed |
| EP-1067130-A1 | TRIAZOLO DERIVATIVES AND CHEMOKINE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | WASF2, COPE, ARCN1 | FDFT1 924/4885FFAR1 493/4885FFAR4 1114/4885 |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | FDFT1 3440/4885FFAR1 1616/4885FFAR4 1772/4885 |
| US-20230210728-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF | KIT, SETD7, SETDB1 | FDFT1 3283/4885FFAR1 3243/4885FFAR4 2711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.